SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000950123-15-002714
Filing Date
2015-02-17
Accepted
2015-02-17 14:32:56
Documents
2
Group Members
ASPIRE CAPITAL PARTNERS, LLCCHRISKO INVESTORS, INC.CHRISTOS KOMISSOPOULOSERIK J. BROWNRED CEDAR CAPITAL CORP.SGM HOLDINGS CORP.STEVEN G. MARTIN

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d874241dsc13ga.htm SC 13G/A 134291
2 EX-99.1 d874241dex991.htm EX-99.1 9034
  Complete submission text file 0000950123-15-002714.txt   145154
Mailing Address 11975 EL CAMINO REAL, SUITE 300 SAN DIEGO, CA 92130
Business Address 11975 EL CAMINO REAL, SUITE 300 SAN DIEGO, CA 92130 (858) 222-8041
APRICUS BIOSCIENCES, INC. (Subject) CIK: 0001017491 (see all company filings)

IRS No.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-53409 | Film No.: 15621086
SIC: 2834 Pharmaceutical Preparations

Mailing Address 155 NORTH WACKER DRIVE SUITE 1600 CHICAGO IL 60606
Business Address 155 NORTH WACKER DRIVE SUITE 1600 CHICAGO IL 60606 312.658.0400
Aspire Capital Fund, LLC (Filed by) CIK: 0001535683 (see all company filings)

IRS No.: 271406279
Type: SC 13G/A